Blood Cancer Journal Impact Factor, Indexing, Ranking

Blood Cancer Journal (BCJ) is a scholarly journal dedicated to publishing research in the field of Medicine. Nature Publishing is the publisher of this esteemed journal. and its abbreviated form is Blood Cancer J.

Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field.

Topics of particular interest include, but are not limited to, the following:

• Preclinical studies of new compounds, especially those that provide mechanistic insights
• Clinical trials and observations
• Reviews related to new drugs and current management of hematologic malignancies
• Novel observations related to new mutations, molecular pathways, and tumor genomics

Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.

Blood Cancer Journal Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Blood Cancer Journal Journal is Blood Cancer J.

The Ranking of Blood Cancer Journal in 2026 is 426. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Impact Factor of Blood Cancer Journal in 2026 is 12.8. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The SCImago of Blood Cancer Journal in 2026 is 3.699. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The H-Index of Blood Cancer Journal in 2026 is 68. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Quartile of Blood Cancer Journal is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Blood Cancer Journal is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. ProQuest
• 6. Medline
• 7. Google Scholar
• 8. DOAJ
• 9. BIOSIS Previews

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of Blood Cancer Journal is Dr Ayalew Tefferi

Blood Cancer Journal Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of Blood Cancer Journal is $4790, £3290, €3790

Blood Cancer Journal Call for paper : Blood Cancer Journal invites original research contributions for consideration of publication in Blood Cancer Journal journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in Blood Cancer Journal involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Medicine.
• Familiarize Yourself: Read and understand the aims and scope of Blood Cancer Journal to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the Blood Cancer Journal guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago